International Life Sciences Awards 2021
Eric Kristiansen • 12 May 2021
Best Breast Cancer Detection Technology Company – USA
Mammogen is the third of three companies operating under the umbrella of a bio innovation studio called IVBioHoldings. Mammogen is a company incubated with a simple mission that has not and will never waiver: to meaningfully improve every aspect of the women’s health market, and to do so by building a company with an overwhelming presence of women at every level.
NEWPORT BEACH, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Mammogen, a female-led predictive health company developing RNA-powered molecular diagnostics for women’s health, today appointed Elise Berman, M.D., as Chief Medical Officer. Dr. Berman brings more than two decades of leadership across breast imaging, medical affairs, and clinical development. She joins Mammogen as the company advances genTRU-breast™ through clinical validation and toward commercialization.
Mammogen has announced the successful completion of a Series A financing round of up to $30 million, marking a significant milestone in the company's mission to transform breast cancer detection through innovative blood-based diagnostics.
Renowned global builder of boards and executive teams aligns with leading women's health innovator, signaling next phase of commercial growth